Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity

被引:18
作者
Ciccia, Francesco [1 ]
Rizzo, Aroldo [2 ]
Alessandro, Riccardo [3 ]
Guggino, Giuliana [1 ]
Maugeri, Rosario [4 ]
Saieva, Laura [3 ]
Cannizzaro, Alessandra [2 ]
Giardina, AnnaRita [1 ]
De Leo, Giacomo [3 ]
Iacopino, Domenico Gerardo [4 ]
Triolo, Giovanni [1 ]
机构
[1] Univ Palermo, Sez Reumatol, Dipartimento Biomed Med Interna & Specialist, I-90127 Palermo, Italy
[2] Univ Palermo, Sez Anat Patol, Azienda Osped Osped Riuniti Villa Sofia Cervello, I-90127 Palermo, Italy
[3] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, I-90127 Palermo, Italy
[4] Univ Palermo, Dipartimento Biomed Sperimentale & Neurosci Clin, I-90127 Palermo, Italy
关键词
IL-22; IL-22R1; IL-17; p-STAT3; polymyositis; dermatomyositis; EXPRESSION; CYTOKINES; MYOSITIS; CELLS;
D O I
10.1093/rheumatology/keu005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methods. Levels of IL-22, IL-22R1, IL-22BP and STAT3 mRNA were quantified by RT-PCR. The expression of IL-22, IL-22R1, IL-22BP and p-STAT3 was also analysed using immunohistochemistry. Results. Significant modulation of the IL-22 pathway was observed in inflammatory myopathic tissues. In particular, a significant overexpression of IL-22 at the protein but not the mRNA level was observed in PM/DM tissues and was correlated with myositis activity. IL-22R1 aberrant expression was also observed among infiltrating mononuclear cells and necrotic muscle cells. IL-22BP, which inhibits IL-22 signalling, was expressed only in some muscle fibres in PM/DM patients. Conclusion. Our findings indicate that the IL-22 pathway is activated in inflammatory myopathic tissues and may be involved in the induction of muscle inflammatory processes and muscle necrosis.
引用
收藏
页码:1307 / 1312
页数:6
相关论文
共 14 条
[1]   Tumor Necrosis Factor-α Regulates Distinct Molecular Pathways and Gene Networks in Cultured Skeletal Muscle Cells [J].
Bhatnagar, Shephali ;
Panguluri, Siva K. ;
Gupta, Sanjay K. ;
Dahiya, Saurabh ;
Lundy, Robert F. ;
Kumar, Ashok .
PLOS ONE, 2010, 5 (10)
[2]   COMPUTER-ASSISTED ANALYSIS OF 153 PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITIS [J].
BOHAN, A ;
PETER, JB ;
BOWMAN, RL ;
PEARSON, CM .
MEDICINE, 1977, 56 (04) :255-286
[3]   TH17 cytokines induce human airway smooth muscle cell migration [J].
Chang, Ying ;
Al-Alwan, Laila ;
Risse, Paul-Andre ;
Roussel, Lucie ;
Rousseau, Simon ;
Halayko, Andrew J. ;
Martin, James G. ;
Hamid, Qutayba ;
Eidelman, David H. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (04) :1046-U311
[4]   Interleukin-17 increases the effects of IL-1β on muscle cells:: arguments for the role of T cells in the pathogenesis of myositis [J].
Chevrel, G ;
Page, G ;
Granet, C ;
Streichenberger, N ;
Varennes, A ;
Miossec, P .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 137 (1-2) :125-133
[5]   Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome [J].
Ciccia, Francesco ;
Guggino, Giuliana ;
Rizzo, Aroldo ;
Ferrante, Angelo ;
Raimondo, Stefania ;
Giardina, AnnaRita ;
Dieli, Francesco ;
Campisi, Giuseppina ;
Alessandro, Riccardo ;
Triolo, Giovanni .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (02) :295-301
[6]   Polymyositis and dermatomyositis [J].
Dalakas, MC ;
Hohlfeld, R .
LANCET, 2003, 362 (9388) :971-982
[7]   Interleukin-1α expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients -: Important pathogenic features independent of inflammatory cell clusters in muscle tissue [J].
Englund, P ;
Nennesmo, I ;
Klareskog, L ;
Lundberg, IE .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1044-1055
[8]   Expression of interleukin-22 in rheumatoid arthritis - Potential role as a proinflammatory cytokine [J].
Ikeuchi, H ;
Kuroiwa, T ;
Hiramatsu, N ;
Kaneko, Y ;
Hiromura, K ;
Ueki, K ;
Nojima, Y .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1037-1046
[9]   Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation [J].
Kebir, Hania ;
Kreymborg, Katharina ;
Ifergan, Igal ;
Dodelet-Devillers, Aurore ;
Cayrol, Romain ;
Bernard, Monique ;
Giuliani, Fabrizio ;
Arbour, Nathalie ;
Becher, Burkhard ;
Prat, Alexandre .
NATURE MEDICINE, 2007, 13 (10) :1173-1175
[10]   Measures of Adult and Juvenile Dermatomyositis, Polymyositis, and Inclusion Body Myositis Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI) [J].
Rider, Lisa G. ;
Werth, Victoria P. ;
Huber, Adam M. ;
Alexanderson, Helene ;
Rao, Anand Prahalad ;
Ruperto, Nicolino ;
Herbelin, Laura ;
Barohn, Richard ;
Isenberg, David ;
Miller, Frederick W. .
ARTHRITIS CARE & RESEARCH, 2011, 63 :S118-S157